DE68923613D1 - Superoxid-dismutaseanaloge mit neuen bindeeigenschaften. - Google Patents
Superoxid-dismutaseanaloge mit neuen bindeeigenschaften.Info
- Publication number
- DE68923613D1 DE68923613D1 DE68923613T DE68923613T DE68923613D1 DE 68923613 D1 DE68923613 D1 DE 68923613D1 DE 68923613 T DE68923613 T DE 68923613T DE 68923613 T DE68923613 T DE 68923613T DE 68923613 D1 DE68923613 D1 DE 68923613D1
- Authority
- DE
- Germany
- Prior art keywords
- sod
- superoxide dismutase
- domain
- binding properties
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 title abstract 5
- 108010012715 Superoxide dismutase Proteins 0.000 title abstract 5
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20651388A | 1988-06-14 | 1988-06-14 | |
PCT/US1989/002462 WO1989012677A1 (en) | 1988-06-14 | 1989-06-06 | Superoxide dismutase analogs having novel binding properties |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68923613D1 true DE68923613D1 (de) | 1995-08-31 |
DE68923613T2 DE68923613T2 (de) | 1996-01-04 |
Family
ID=22766731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68923613T Expired - Fee Related DE68923613T2 (de) | 1988-06-14 | 1989-06-06 | Superoxid-dismutaseanaloge mit neuen bindeeigenschaften. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0416037B1 (de) |
JP (1) | JP2942578B2 (de) |
AT (1) | ATE125566T1 (de) |
CA (1) | CA1335577C (de) |
DE (1) | DE68923613T2 (de) |
WO (1) | WO1989012677A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2878341B2 (ja) * | 1989-03-03 | 1999-04-05 | 学校法人藤田学園 | 人工機能性ポリペプチド |
DE69027383T2 (de) * | 1989-03-06 | 1996-11-14 | Suntory Ltd | Neue superoxyd-dismutase |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
US10597660B2 (en) | 2014-11-14 | 2020-03-24 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
US11603542B2 (en) | 2017-05-05 | 2023-03-14 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
AU2018352236A1 (en) | 2017-10-16 | 2020-04-23 | The Curators Of The University Of Missouri | Treatment of amyotrophic lateral sclerosis (ALS) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0013810A3 (de) * | 1979-01-24 | 1981-07-15 | Imperial Chemical Industries Plc | Verfahren und Vorrichtung zur Herstellung von Zündschnur |
EP0138111B1 (de) * | 1983-10-03 | 1991-11-21 | Chiron Corporation | Klonieren von Superoxid-Dismutase und Expression in Mikroorganismen |
GB8516421D0 (en) * | 1985-06-28 | 1985-07-31 | Biotechnology Interface Ltd | Fibronectins |
-
1989
- 1989-06-06 WO PCT/US1989/002462 patent/WO1989012677A1/en active IP Right Grant
- 1989-06-06 JP JP1506887A patent/JP2942578B2/ja not_active Expired - Fee Related
- 1989-06-06 EP EP89907516A patent/EP0416037B1/de not_active Expired - Lifetime
- 1989-06-06 AT AT89907516T patent/ATE125566T1/de not_active IP Right Cessation
- 1989-06-06 DE DE68923613T patent/DE68923613T2/de not_active Expired - Fee Related
- 1989-06-07 CA CA000602018A patent/CA1335577C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0416037A4 (en) | 1991-11-13 |
EP0416037B1 (de) | 1995-07-26 |
WO1989012677A1 (en) | 1989-12-28 |
JP2942578B2 (ja) | 1999-08-30 |
EP0416037A1 (de) | 1991-03-13 |
ATE125566T1 (de) | 1995-08-15 |
CA1335577C (en) | 1995-05-16 |
DE68923613T2 (de) | 1996-01-04 |
JPH03505398A (ja) | 1991-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8902376D0 (sv) | Foerfarande foer framstaellning av ett vaevnadsbindemedel | |
ATE196428T1 (de) | Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen | |
MC2144A1 (fr) | Peptides therapeutiques | |
LU90458I2 (fr) | Refacto | |
FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
DE69233068D1 (de) | Serin-reiche peptidlinker | |
NO871574D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive peptider. | |
ATE54826T1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
NO940299L (no) | Peptid med organbeskyttende aktivitet | |
DE68917837T2 (de) | Peptid-Verbindungen. | |
US6096864A (en) | Peptides for use in wound treatment | |
DE68923613D1 (de) | Superoxid-dismutaseanaloge mit neuen bindeeigenschaften. | |
ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
ATE60788T1 (de) | Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen. | |
ES2054765T3 (es) | Peptidos con contenido de glutamina, procedimiento para su preparacion y empleo. | |
ATE92078T1 (de) | Pharmakologisch aktive peptide. | |
ATE96035T1 (de) | Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |